Introduction: The aim of this study was to assess the prognostic value of the preoperative serum ferritin-to-transferrin ratio (FTR) in renal cell carcinoma (RCC). Methods: We retrospectively reviewed data from 226 patients who underwent surgery for nonmetastatic RCC at our institution between January 1, 2012, and June 30, 2021. Time-dependent receiver operating characteristic (timeROC) analysis identified the optimal FTR cut-off, dividing patients into high and low FTR groups. Propensity score matching (PSM) adjusted for baseline differences. Recurrence-free survival (RFS) and overall survival (OS) were analysed using the Kaplan-Meier method and Cox regression, with a nomogram validating the results. Results: The timeROC analysis showed a 5-year area under the curve of 0.786 for FTR, with 68.4% sensitivity and 86.7% specificity at a cut-off of 177.1. High FTR and clinical stage were independent risk factors for OS and RFS. The hazard ratios for OS and RFS in the high and low FTR groups were 2.598 (1.087–6.213), p = 0.032 and 2.591 (1.105–6.074), p = 0.029, respectively. Kaplan-Meier curves showed significant differences post-PSM (log rank p < 0.05). The nomogram validation indicated high predictive accuracy with a C-index of 0.867 (95% CI: 0.836–0.899) for OS and 0.808 (95% CI: 0.764–0.852) for RFS. Conclusion: Our findings suggest that FTR may serve as an independent prognostic risk factor in patients with locally and localized advanced RCC.

1.
Sung
H
,
Ferlay
J
,
Siegel
RL
,
Laversanne
M
,
Soerjomataram
I
,
Jemal
A
, et al
.
Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2021
;
71
(
3
):
209
49
.
2.
Choueiri
TK
,
Tomczak
P
,
Park
SH
,
Venugopal
B
,
Ferguson
T
,
Chang
YH
, et al
.
Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma
.
N Engl J Med
.
2021
;
385
(
8
):
683
94
.
3.
Bedke
J
,
Albiges
L
,
Capitanio
U
,
Giles
RH
,
Hora
M
,
Lam
TB
, et al
.
2021 updated European association of urology guidelines on the use of adjuvant pembrolizumab for renal cell carcinoma
.
Eur Urol
.
2022
;
81
(
2
):
134
7
.
4.
Messina
C
,
Zanardi
E
,
Boccardo
F
.
May adjuvant therapy play A role for the management of renal cell carcinoma? A review of literature and ongoing trials
.
Anticancer Agents Med Chem
.
2017
;
17
(
12
):
1633
43
.
5.
Mjaess
G
,
Chebel
R
,
Karam
A
,
Moussa
I
,
Pretot
D
,
Abi Tayeh
G
, et al
.
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses
.
Acta Oncol
.
2021
;
60
(
6
):
704
13
.
6.
Wang
Q
,
Zhu
SR
,
Huang
XP
,
Liu
XQ
,
Liu
JB
,
Tian
G
.
Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis
.
Eur Rev Med Pharmacol Sci
.
2021
;
25
(
3
):
1302
10
.
7.
Wang
SL
,
Cao
S
,
Wu
R
,
Chi
F
,
Tang
MY
,
Jin
XY
, et al
.
Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer
.
Future Oncol
.
2015
;
11
(
21
):
2905
10
.
8.
Ji
M
,
Li
XD
,
Shi
HB
,
Ning
ZH
,
Zhao
WQ
,
Wang
Q
, et al
.
Clinical significance of serum ferritin in elderly patients with primary lung carcinoma
.
Tumour Biol
.
2014
;
35
(
10
):
10195
9
.
9.
Wu
SJ
,
Zhang
ZZ
,
Cheng
NS
,
Xiong
XZ
,
Yang
L
.
Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy
.
Surg Oncol
.
2019
;
29
:
159
67
.
10.
Cheng
Z
,
Akatsuka
S
,
Li
GH
,
Mori
K
,
Takahashi
T
,
Toyokuni
S
.
Ferroptosis resistance determines high susceptibility of murine A/J strain to iron-induced renal carcinogenesis
.
Cancer Sci
.
2022
;
113
(
1
):
65
78
.
11.
Xing
XL
,
Yao
ZY
,
Ou
J
,
Xing
C
,
Li
F
.
Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
.
Cancer Cel Int
.
2021
;
21
(
1
):
591
.
12.
Essen
A
,
Ozen
H
,
Ayhan
A
,
Ergen
A
,
Tasar
C
,
Remzi
F
.
Serum ferritin: a tumor marker for renal cell carcinoma
.
J Urol
.
1991
;
145
(
6
):
1134
7
.
13.
Kirkali
Z
,
Güzelsoy
M
,
Mungan
MU
,
Kirkali
G
,
Yörükoglu
K
.
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume
.
Urol Int
.
1999
;
62
(
1
):
21
5
.
14.
Forciniti
S
,
Greco
L
,
Grizzi
F
,
Malesci
A
,
Laghi
L
.
Iron metabolism in cancer progression
.
Int J Mol Sci
.
2020
;
21
(
6
):
2257
.
15.
Chen
PH
,
Wu
J
,
Ding
CKC
,
Lin
CC
,
Pan
S
,
Bossa
N
, et al
.
Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism
.
Cell Death Differ
.
2020
;
27
(
3
):
1008
22
.
16.
Cullis
JO
,
Fitzsimons
EJ
,
Griffiths
WJ
,
Tsochatzis
E
,
Thomas
DW
;
British Society for Haematology
.
Investigation and management of a raised serum ferritin
.
Br J Haematol
.
2018
;
181
(
3
):
331
40
.
17.
Blom
JH
,
van Poppel
H
,
Maréchal
JM
,
Jacqmin
D
,
Schröder
FH
,
de Prijck
L
, et al
.
Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881
.
Eur Urol
.
2009
;
55
(
1
):
28
34
.
18.
Marchioni
M
,
Bandini
M
,
Pompe
RS
,
Martel
T
,
Tian
Z
,
Shariat
SF
, et al
.
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy
.
BJU Int
.
2018
;
121
(
3
):
383
92
.
19.
Kirkali
Z
,
Esen
AA
,
Kirkali
G
,
Güner
G
.
Ferritin: a tumor marker expressed by renal cell carcinoma
.
Eur Urol
.
1995
;
28
(
2
):
131
4
.
20.
Singh
KJ
,
Singh
SK
,
Suri
A
,
Vijjan
V
,
Goswami
AK
,
Khullar
M
.
Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage
.
Indian J Cancer
.
2005
;
42
(
4
):
197
200
.
21.
Huang
H
,
Qiu
Y
,
Huang
G
,
Zhou
X
,
Zhou
X
,
Luo
W
.
Value of ferritin heavy chain (FTH1) expression in diagnosis and prognosis of renal cell carcinoma
.
Med Sci Monit
.
2019
;
25
:
3700
15
.
22.
Miyata
Y
,
Koga
S
,
Nishikido
M
,
Hayashi
T
,
Kanetake
H
.
Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma
.
BJU Int
.
2001
;
88
(
9
):
974
7
.
23.
Beer
T
,
Vadakara
J
.
Etiologies and short-term mortality in patients with ultraelevated serum ferritin
.
South Med J
.
2015
;
108
(
9
):
574
8
.
24.
Mannello
F
,
Tonti
GA
,
Medda
V
,
Simone
P
,
Darbre
PD
.
Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients
.
J Appl Toxicol
.
2011
;
31
(
3
):
262
9
.
25.
Chen
Y
,
Fan
Z
,
Yang
Y
,
Gu
C
.
Iron metabolism and its contribution to cancer (Review)
.
Int J Oncol
.
2019
;
54
(
4
):
1143
54
.
26.
Dixon
SJ
,
Lemberg
KM
,
Lamprecht
MR
,
Skouta
R
,
Zaitsev
EM
,
Gleason
CE
, et al
.
Ferroptosis: an iron-dependent form of nonapoptotic cell death
.
Cell
.
2012
;
149
(
5
):
1060
72
.
27.
Zhou
L
,
Zhao
B
,
Zhang
L
,
Wang
S
,
Dong
D
,
Lv
H
, et al
.
Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer
.
Int J Mol Sci
.
2018
;
19
(
5
):
1545
.
28.
Manz
DH
,
Blanchette
NL
,
Paul
BT
,
Torti
FM
,
Torti
SV
.
Iron and cancer: recent insights
.
Ann N Y Acad Sci
.
2016
;
1368
(
1
):
149
61
.
29.
Chen
GQ
,
Benthani
FA
,
Wu
J
,
Liang
D
,
Bian
ZX
,
Jiang
X
.
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
.
Cel Death Differ
.
2020
;
27
(
1
):
242
54
.
30.
Chen
X
,
Kang
R
,
Kroemer
G
,
Tang
D
.
Broadening horizons: the role of ferroptosis in cancer
.
Nat Rev Clin Oncol
.
2021
;
18
(
5
):
280
96
.
You do not currently have access to this content.